Pufenc News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Pufenc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Pufenc Today - Breaking & Trending Today
Fennec Pharmaceuticals Inc (NASDAQ:FENC – Get Free Report) COO Adrian Haigh sold 22,223 shares of Fennec Pharmaceuticals stock in a transaction that occurred on Monday, April 22nd. The shares were sold at an average price of $9.32, for a total transaction of $207,118.36. The transaction was disclosed in a legal filing with the SEC, which […] ....
Fennec Pharmaceuticals Inc (NASDAQ:FENC – Get Free Report) COO Adrian Haigh sold 22,222 shares of the company’s stock in a transaction dated Friday, April 19th. The shares were sold at an average price of $9.34, for a total transaction of $207,553.48. The transaction was disclosed in a legal filing with the SEC, which can be […] ....
Fennec Pharmaceuticals Inc (NASDAQ:FENC – Get Free Report) COO Adrian Haigh sold 22,222 shares of the business’s stock in a transaction that occurred on Friday, April 19th. The stock was sold at an average price of $9.34, for a total transaction of $207,553.48. The transaction was disclosed in a filing with the Securities & Exchange […] ....
Fennec Pharmaceuticals Inc (NASDAQ:FENC – Get Free Report) CEO Rosty Raykov sold 40,584 shares of the business’s stock in a transaction dated Wednesday, April 3rd. The shares were sold at an average price of $10.78, for a total transaction of $437,495.52. Following the completion of the sale, the chief executive officer now owns 276,054 shares […] ....
Fennec Pharmaceuticals (NASDAQ:FENC – Get Free Report) released its earnings results on Monday. The company reported ($0.07) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.11) by $0.04, MarketWatch Earnings reports. The firm had revenue of $6.52 million during the quarter, compared to the consensus estimate of $5.22 million. During the same […] ....